Table 1 Clinicopathologic characteristics of HCC patients between survival and non-survival groups

Gender (M/F)

54/10

65/15

NS

Age (yrs)

54.5 ± 10.3

52.0 ± 9.85

NS

HBsAg (Y/N)

48/16

62/18

NS

Cirrhosis (Y/N)

44/20

49/31

NS

Tumor Size

4.55 ± 2.13

7.93 ± 3.33

0.000

Number of tumors (S/M)

59/5

67/13

NS

AFP ≥ 400 (Y/N)

12/52

43/37

0.0001

AST (U/L)

49.9 ± 35.0

52.0 ± 36.3

NS

ALT (U/L)

45.2 ± 21.4

56.2 ± 42.2

NS

Scr (µmol/L)

71.1 ± 14.8

71.3 ± 16.2

NS

Hospital duration

20.6 ± 7.03

21.4 ± 8.47

NS

Differentiation

21/43

46/34

0.003

Child-Pugh Score

A

57

70

0.773

B

7

10

TMN Grade (I/II/III)

I

48

12

0.000

II

16

21

III

0

47

NLR

2.80 ± 1.89

3.79 ± 3.29

0.000

ALBI grade

I

48

39

0.001

II

16

41

NLR-ALBI

Score 1

34

17

0.000

Score 2

24

34

Score 3

8

27